Buscador de publicacions

Publicacions

  • Ribó-Gené S, Sánchez-Infantes D, Martínez-Guino L, García-Mantrana I, Ramon-Krauel M, Tondo M, Arning E, Nofrarías M, Osorio-Conles Ó, Fernández-Pérez A, González-Torres P, Cebrià-Romero J, Gavalda A, Chenoll E, Isganaitis E, Villarroya F, Vallejo M, Segalés J, Jimenez-Chillaron JC, Bottiglieri T, Demerath EW, Fields DA, Collado MC and Lerin-Martinez C.

    Increasing breast milk betaine modulates Akkermansia abundance in mammalian neonates and improves long-term metabolic health.

    SCIENCE TRANSLATIONAL MEDICINE . 13(587): . Nº de cites: 2

    [doi:10.1126/scitranslmed.abb0322]

  • de Zegher F, Díaz-Silva M, Villarroya J, Cairo M, López-Bermejo A, Villarroya F and Ibañez-Toda L.

    The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat.

    SCIENTIFIC REPORTS . 11(1): 7018-7018.

    [doi:10.1038/s41598-021-86317-9]

  • Cereijo R, Quesada T, Gavalda A, Tarascó J, Pellitero S, Reyes M, Puig-Domingo M, Giralt M, Sánchez-Infantes D and Villarroya F.

    The chemokine CXCL14 is negatively associated with obesity and concomitant type-2 diabetes in humans.

    INTERNATIONAL JOURNAL OF OBESITY . 45(3): 706-710.

    [doi:10.1038/s41366-020-00732-y]

  • Ferrer G, Guitart-Mampel M, Ruperez CH, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Villarroya F, Fernández-Solà J, Garrabou G and Planavila A.

    The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.

    J PATHOL . 253(2): 198-208.

    [doi:10.1002/path.5573]

  • Moron S, Uriarte I, Berasain C, Avila MA, Sabater-Masdeu M, Moreno-Navarrete JM, Fernández-Real JM, Giralt M, Villarroya F and Gavalda A.

    FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations.

    molecular metabolism . 43: 101113-101113.

    [doi:10.1016/j.molmet.2020.101113]

  • Carneros D, Medina-Gómez G, Giralt M, León-Camacho M, Campbell M, Moreno-Aliaga MJ, Villarroya F and Bustos M.

    Cardiotrophin-1 contributes to metabolic adaptations through the regulation of lipid metabolism and to the fasting-induced fatty acid mobilization.

    FASEB JOURNAL . 34(12): 15875-15887.

    [doi:10.1096/fj.202000109R]

  • Campderros L, Sánchez-Infantes D, Villarroya J, Nescolarde L, Bayès-Genis A, Cereijo R, Roca E and Villarroya F.

    Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners.

    FRONTIERS IN PHYSIOLOGY . 11: 550102-550102. Nº de cites: 2

    [doi:10.3389/fphys.2020.550102]

  • Frohlich J, Kovacovicova K, Mazza T, Emma MR, Cabibi D, Foti M, Sobolewski C, Oben JA, Peyrou M, Villarroya F, Soresi M, Rezzani R, Cervello M, Bonomini F, Alisi A and Vinciguerra M.

    GDF11 induces mild hepatic fibrosis independent of metabolic health.

    Aging-Us . 12(20): 20024-20046. Nº de cites: 4

    [doi:10.18632/aging.104182]

  • Molonia MS, Occhiuto C, Muscarà C, Speciale A, Bashllari R, Villarroya F, Saija A, Cimino F and Cristani M.

    Cyanidin-3-O-glucoside restores insulin signaling and reduces inflammation in hypertrophic adipocytes.

    ARCH BIOCHEM BIOPHYS . 691: 108488-108488.

    [doi:10.1016/j.abb.2020.108488]

  • Barroso E, Rodríguez-Rodríguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer FX, Villarroya F and Vazquez M.

    SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1a-LIPIN 1 pathway and increasing CD36 through Nrf2.

    CELL COMMUN SIGNAL . 18(1): 147-147.

    [doi:10.1186/s12964-020-00640-8]